cbdMD, Inc.
YCBD- Exchange
- NYSE
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- SEC CIK
- 0001644903
No open-market purchases or sales by cbdMD, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $611.7K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 27
- 13F valueReported value at the end of Q2 2026
- $611.7K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding YCBD, Q2 2026
No superinvestor reported holding YCBD at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by cbdMD, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 (view filing) | Dec 17 | 2 days | Crosnoe Clark R.10% Owner | SSale | −550.7K | $2.31 | −$1.27M | −96.9%17.9K after | 3 lots |
| Sep 30, 2024 (view filing) | Sep 26 | 4 days | Kennedy Thomas RonanCEO and CFO | PPurchase | +4 | $137.50 | +$550 | –41.8K after | Derivative |
| Sep 25, 2024 (view filing) | Sep 23 | 2 days | Kennedy Thomas RonanCEO and CFO | PPurchase | +143 | $161.39 | +$23.1K | –40.8K after | Derivative |
| May 5, 2023 (view filing) | May 3 | 2 days | Kennedy Thomas RonanInterim CEO and CFO | PPurchase | −5.00K | $2.10 | −$10.5K | −43.6%6.46K after | |
| Aug 25, 2021 (view filing) | Aug 24 | 1 day | Kennedy Thomas RonanCFO & COO | PPurchase | +7.40K | $2.04 | +$15.1K | New position7.40K after | |
| Aug 25, 2021 (view filing) | Aug 24 | 1 day | Kennedy Thomas RonanCFO & COO | PPurchase | +3.83K | $3.91 | +$15.0K | –2.30K after | Derivative |
| Aug 20, 2021 (view filing) | Aug 18 | 2 days | Wiesehan John J IIIChief Revenue Officer | PPurchase | +3.33K | $4.18 | +$13.9K | –2.00K after | Derivative |
| Jul 26, 2021 (view filing) | Jul 22 | 4 days | Wiesehan John J IIIChief Revenue Officer | PPurchase | +161.6K | – | – | New position161.6K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in cbdMD, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Worth Venture Partners, LLC | 184,796 | $124.4K | 0.28% | 00.0% | Unchanged |
| CSS LLC | 137,621 | $92.6K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 119,645 | $80.5K | 0.00% | +68,592+134.4% | Added |
| Chapin Davis, Inc. | 81,250 | $54.7K | 0.01% | 00.0% | Unchanged |
| Alesco Advisors LLC | 68,513 | $46.1K | 0.00% | 00.0% | Unchanged |
| Chicago Partners Investment Group LLC | 78,098 | $45.0K | 0.00% | +64,598+478.5% | Added |
| XTX Topco Ltd | 62,743 | $42.2K | 0.00% | −29,306−31.8% | Reduced |
| Jane Street Group, LLC | 54,401 | $36.6K | 0.00% | −21,937−28.7% | Reduced |
| Vanguard Fiduciary Trust Co | 47,157 | $31.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 21,576 | $14.5K | 0.00% | −143,067−86.9% | Reduced |